TWi Biotechnology (ROCO:6610) Marketable Securities : NT$48.80 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is TWi Biotechnology Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. TWi Biotechnology's Marketable Securities for the quarter that ended in Dec. 2024 was NT$48.80 Mil.

TWi Biotechnology's annual Marketable Securities increased from Dec. 2022 (NT$0.00 Mil) to Dec. 2023 (NT$171.85 Mil) but then declined from Dec. 2023 (NT$171.85 Mil) to Dec. 2024 (NT$48.80 Mil).

TWi Biotechnology Marketable Securities Historical Data

The historical data trend for TWi Biotechnology's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TWi Biotechnology Marketable Securities Chart

TWi Biotechnology Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

148.20

34.30

171.85

48.80

TWi Biotechnology Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Marketable Securities	Get a 7-Day Free Trial															-	-	171.85	32.13	48.80

TWi Biotechnology Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

TWi Biotechnology (ROCO:6610) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

TWi Biotechnology Marketable Securities Related Terms

Thank you for viewing the detailed overview of TWi Biotechnology's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

TWi Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TWi Biotechnology Inc (ROCO:6610) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 221, Kang Chien Road, 8th Floor, Number 41, Neihu District, Taipei, TWN, 11494

Website

https://www.twibiotech.com

TWi Biotechnology Inc is a clinical-stage biopharmaceutical company based in Taiwan. It is engaged in the development of new drugs for unmet medical needs, particularly in the diseases associated with innate immunity. The pipeline products of the company comprise AC-201, AC-203, and AC-701.

TWi Biotechnology Headlines

No Headlines